Drug Repurposing: Can Drugs for Other Diseases Benefit People with MBC?
Drugs approved by the FDA for one disease or condition can sometimes be used to treat people with other diseases or conditions. This is called “drug repurposing”...
Read More PAST ARTICLES
2025
2024
- Combining Radiation and Immunotherapy Treatment for MBC
- Can I Know if My MBC Treatment is Likely to Work?
- The Latest in Treatments for MBC With Brain Metastases
- What You Need to Know About De Novo MBC Research
- Update on Oral SERDs and New Types of Hormone Therapies
- Turning “Cold” Tumors Into “Hot” Tumors: Researching How to Make Immunotherapy Work in More People With MBC
- Targeting the Androgen Receptor in MBC
- Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC
- Leptomeningeal Disease: How is it Different from Brain Metastasis and How is it Treated?
- Discovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC
2023
- What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
- Why Are MBC Outcomes Worse for Black Women Than White Women?
- Overcoming Resistance to CDK4/6 Inhibitors
- Researching Ways to Make MBC Treatment Easier to Tolerate
- Artificial Intelligence and MBC: Can AI Improve Detection and Treatment?
- The Latest Research on Lobular MBC
- What is the Microbiome and How Might it Affect MBC?
- New ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
2022
- The Latest Research on CDK 4/6 Inhibitors
- Why You Should Consider Repeat Biopsies
- Oncolytic Viruses: Using Viruses to Kill Cancer Cells
- Why Knowing Your HER2 Status is Important
- All About Vaccines for MBC
- Triple-Negative Metastatic Breast Cancer: Beyond ER, PR, and HER2
- Update on Immunotherapy for MBC: Immune Checkpoint Inhibitors
- Update On Antibody-Drug Conjugates (ADCs) For MBC
- Bispecific Antibodies: An Emerging Class Of MBC Drugs
2021
- What do FGFR Genetic Mutations Mean for You and Your MBC?
- Metronomic Chemotherapy: Looking at A New Way to Receive Treatment
- Inflammatory MBC Treatments
- Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
- Cell-Based Therapies: A Type of Immunotherapy for MBC
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- Y-90 Internal Radiation Therapy for Liver Mets
- The Latest Research on Hormone Receptor-Positive (HR+) MBC
- 2021 Update on Metastatic Triple Negative Breast Cancer Treatment
- Treating Breast Cancer Brain Mets
- Lines of Therapy: New Drugs May Change MBC Treatment
2020
- When to Use Surgery & Radiation to the Breast
- HER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
- Different Types of Imaging Scans: How, When, and Why They are Used
- PD-L1 Biomarker for Immunotherapy
- What is ER-Low Breast Cancer?
- HER2 Positive Metastatic Breast Cancer Research Update
- Recent FDA Approvals for Metastatic Breast Cancer
- The Tumor Microenvironment
- What is Your Tumor’s Mutation Burden?
- Triple-Negative Breast Cancer Update
2019
- Tips for Reading Cancer News
- What is a Tumor Agnostic Therapy?
- Treating Brain Metastases
- New FDA Approval: A PI3K Inhibitor
- What is Oligometastatic Breast Cancer?
- First Immunotherapy Approved for MBC
- The Latest Research on ctDNA and MBC
- Get the Latest News on PARP Inhibitors
- New Research Presented at San Antonio
SEARCH OUR SITE
for past articles or specific information.